Overview

Detailed Summary

Albert David Limited (ADL) specializes in manufacturing and trading pharmaceutical formulations, infusion solutions, herbal dosage forms, and bulk drugs, both domestically and internationally.
The company is a significant player in the IV fluid manufacturing sector, with production capabilities in both glass and polyethylene containers.
ADL has engaged in several technical collaborations, notably with Morishita Pharmaceuticals for amino acid infusions and Pharma Plan, Germany for syringe and needle manufacturing.
Over the years, ADL has consistently launched new pharmaceutical products across various categories, reflecting its focus on innovation and market adaptation.
ADL is part of the Kothari Group, a prominent industrial house in Kolkata, highlighting a strong backing in capital and strategic direction.

Sector: Pharmaceuticals & Biotechnology
Industry: Pharmaceuticals
Market Cap: 391 Cr
Volatility: Moderate Risk
P/E Ratio: 40.7
Industry P/E: 32.6
PEG Ratio: —
P/B Ratio: 1.0
52W High: 959.35
52W Low: 642.00

Sales CAGR

1Y: -4.60%
3Y: 3.32%
5Y: 1.51%
10Y: 0.39%

Profit CAGR

1Y: -77.19%
3Y: -21.28%
5Y: -2.14%
10Y: -10.78%

ROE

TTM: -3.83%
3Y: 11.85%
5Y: 11.56%
10Y: 11.99%

ROCE

TTM: -3.33%
3Y: 15.43%
5Y: 14.86%
10Y: 15.76%

Technicals

‌

Forecasts

Peers

Healthcare Healthcare Pharmaceuticals

Symbol	Price	Market Cap	P/E	P/B	Div Yield (%)	ROE (%)	ROCE (%)	ROA (%)
JENBURPH	1010.00	443 Cr	13.75	2.42	1.79	18.04	24.68	15.51
ALBERTDAVD	685.00	391 Cr	40.70	0.99	0.73	-3.83	-3.33	1.80
AMANTA	99.00	383 Cr	26.68	1.82	0.00	7.41	11.89	3.14
HALEOSLABS	1262.00	382 Cr	19.22	1.85	0.12	9.06	12.31	5.32
MEDICAMEQ	273.30	377 Cr	51.29	1.37	0.34	3.88	4.69	1.96
ZIMLAB	64.35	347 Cr	44.69	1.21	0.00	2.62	6.18	1.50
INFINIUM	211.75	330 Cr	37.81	3.01	0.00	8.14	13.29	5.02
Median: 7 Co.	273.30	382 Cr	37.81	1.82	0.12	7.41	11.89	3.14

Financial Statements

AI Powered Summary

Discover detailed, AI-driven financial summaries that break down key metrics, trends, and insights—empowering you to make smarter investment decisions.

Ask AI

Standalone Quarterly Results (in ₹ Crores)

Total Figures

QoQ Changes

Total Figures

	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025
Sales	93	88	89	89	98	83	75	71	87	90
Expenses	77	80	79	88	92	82	80	81	85	79
Operating Profit	16	8.35	9.57	0.89	6.23	0.67	-4.75	-11	2.54	11
OPM %	17.14	9.46	10.75	1.00	6.33	0.81	-6.34	-15.09	2.91	12.03
Other Income	12	17	10	23	21	-9.01	-5.11	22	-2.14	12
Interest	0.06	0.12	0.07	0.09	0.06	0.13	0.13	0.55	0.75	0.90
Depreciation	1.46	1.68	1.83	1.79	1.67	1.70	1.82	2.39	2.23	2.42
Profit Before Tax	27	23	18	22	25	-10	-12	8.44	-2.58	20
Tax %	23.54	20.14	28.71	14.60	28.09	7.58	12.53	5.92	-27.91	23.12
Net Profit	20	19	13	19	18	-9.39	-10	7.94	-3.30	15
EPS in Rs	35.57	32.80	22.63	33.02	31.67	-16.45	-18.10	13.91	-5.79	26.81

Standalone Profit Loss (in ₹ Crores)

Total Figures

YoY Changes

Total Figures

	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	TTM
Sales	306	289	317	321	247	314	342	362	346	327
Expenses	267	266	287	290	228	273	297	316	343	335
Operating Profit	39	23	30	30	19	41	44	47	3.03	-8.50
OPM %	12.73	8.05	9.36	9.45	7.74	13.01	12.98	12.93	0.88	-2.60
Other Income	7.62	8.91	6.79	7.11	17	16	15	58	30	29
Interest	0.74	0.86	0.62	0.80	0.65	0.53	0.46	0.32	0.41	0.87
Depreciation	7.52	8.23	6.98	7.67	8.23	8.81	8.55	6.83	6.97	7.58
Profit Before Tax	27	22	29	29	27	47	51	97	25	12
Tax %	37.35	37.42	38.57	33.80	19.31	25.45	28.70	22.48	31.82	45.78
Net Profit	17	13	18	19	22	35	36	75	17	6.29
EPS in Rs	27.96	17.23	46.69	33.58	38.80	61.77	63.39	132.16	30.14	16.83
Dividend Payout %	19.67	31.90	12.85	20.84	15.46	14.57	14.20	8.70	16.59	—

Standalone Balance Sheet (in ₹ Crores)

Total Figures

YoY Changes

Total Figures

	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Equity Capital	5.71	5.71	5.71	5.71	5.71	5.71	5.71	5.71	5.71	5.71
Reserves	131	177	180	205	217	239	274	306	377	387
Borrowings	20	30	28	0.44	1.44	1.62	5.66	5.32	3.32	12
Other Liabilities	67	71	76	84	96	95	116	107	112	107
Total Liabilities	224	285	290	295	320	341	401	423	498	511
Fixed Assets	44	87	83	77	91	84	88	80	83	99
CWIP	5.01	8.67	5.25	5.06	1.52	0.75	0.81	2.72	6.74	1.92
Investments	48	59	68	113	122	138	183	193	273	260
Other Assets	127	130	134	99	106	119	130	148	135	151
Total Assets	224	285	290	295	320	341	401	423	498	511

Standalone Cash Flows (in ₹ Crores)

Total Figures

YoY Changes

Total Figures

	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Cash from Operating Activity	68	20	30	32	30	37	40	11	46	-28
Cash from Investing Activity	-38	-37	-11	-19	-20	-39	-40	-5.00	-33	23
Cash from Financing Activity	-18	6.69	-4.56	-17	-10	-1.71	-1.59	-6.36	-8.27	0.11
Net Cash Flow	12	-10	14	-4.29	-0.08	-3.78	-0.88	-0.84	3.98	-5.02

Shareholdings

Shareholding History

Quarterly

Yearly

Quarterly

	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025
Promoters	62.04%	62.04%	62.04%	62.04%	62.13%	62.13%	62.13%	62.13%	62.24%	62.24%	62.24%	62.24%
FIIs	0.57%	0.65%	0.57%	0.70%	0.98%	0.80%	0.88%	0.86%	1.01%	0.84%	0.60%	0.60%
DIIs	2.80%	2.30%	1.90%	1.67%	1.67%	1.67%	1.64%	1.64%	1.65%	1.66%	1.66%	1.66%
Public	34.59%	35.01%	35.48%	35.59%	35.22%	35.40%	35.35%	35.37%	35.11%	35.26%	35.50%	35.50%
Total Shareholders	9,786	9,828	9,907	10,041	11,266	12,349	13,590	14,830	15,304	15,070	14,666	13,967

Market Transactions

Unlock Premium Features

Analyst Target, Price, EPS and Revenue Projections

Upgrade

Projection

Documents

Presentations

Concalls

Reports

Presentations

No documents found!

Actions

Action Type

‌
‌

Announcements

Last 7 days

Newest

Sentiment

Change in Management

2 days ago

International Business Leader Resignation at Albert David

Albert David Ltd informs that Mr. Thakkar Rushabh Kishorbhai, International Business Leader, has resigned effective at close of business on 27 Mar 2026, citing a better job opportunity; company records appreciation.

AI Mode

Get instant AI-powered insights about company performance, financials, and strategy. Ask questions about trends, competition, and developments while receiving responses backed by official documents and market data, with clear attribution to source documents.

Ask AI

Frequently Asked Questions about Albert David Ltd

Albert David Ltd (ALBERTDAVD) is currently trading at 685.00 per share. Stock prices fluctuate during market hours on NSE and BSE based on demand, company updates, and overall market conditions. Refer to the live price chart above for the most recent price movement.

Albert David Limited (ADL) specializes in manufacturing and trading pharmaceutical formulations, infusion solutions, herbal dosage forms, and bulk drugs, both domestically and internationally. The company is a significant player in the IV fluid manufacturing sector, with production capabilities in both glass and polyethylene containers. ADL has engaged in several technical collaborations, notably with Morishita Pharmaceuticals for amino acid infusions and Pharma Plan, Germany for syringe and needle manufacturing. Over the years, ADL has consistently launched new pharmaceutical products across various categories, reflecting its focus on innovation and market adaptation. ADL is part of the Kothari Group, a prominent industrial house in Kolkata, highlighting a strong backing in capital and strategic direction.

Over the past 52 weeks, Albert David Ltd has traded between a low of ₹642.00 and a high of ₹959.35. The 52-week high and low indicate the stock’s price range over the last year and help investors understand its volatility and recent trading levels.

Albert David Ltd has a market capitalization of approximately 391.14. Market capitalization represents the total value of a company’s outstanding shares and helps investors understand its size, stability, and relative risk compared to other listed companies.

Albert David Ltd’s investment profile depends on its business fundamentals, valuation, and long-term outlook. The stock currently trades at a PE ratio of 40.70 and operates in the its sector sector. Investors typically assess financial performance, growth prospects, and individual risk tolerance before making investment decisions.

Based on its market capitalization of 391.14 Cr, Albert David Ltd is classified as a Small Cap stock. Large-cap stocks are generally more stable, while mid-cap and small-cap stocks tend to offer higher growth potential along with higher price volatility.

Albert David Ltd operates in the its sector sector. Sector classification matters because companies in the same sector are often affected by similar economic conditions, regulatory changes, and competitive dynamics, which can influence overall stock performance.

The Price-to-Earnings (PE) ratio of Albert David Ltd is 40.70. The PE ratio compares a company’s share price to its earnings and is commonly used to assess valuation. Comparing the PE ratio with sector peers and historical levels provides better context.

Albert David Ltd

Stock Summary and Key Metrics

Investment Checklist

Investment Checklist

Overview

Financial Ratios

Technicals

Forecasts

Peers

Price Chart Comparison